PER 4.94% 8.5¢ percheron therapeutics limited

Ann: PIIb DMD trial approved in Bulgaria- UK, Australia advancing, page-20

  1. 2,559 Posts.
    lightbulb Created with Sketch. 327
    As much as management wants to keep retail happy, the best and only thing they can do is "DO A GOOD JOB & INVENT NEW MEDICATIONS"
    Beyond that its the ruthlessness of the market that dictates how it travels. If good results are not delivered, ability to command
    price is just not there. The capital raise participants take advantage and make the retail hold the hot potato while they enjoy
    the riches. They don't stop just there. As even the management depend on them for recurring raises required for remuneration etc, they take
    the position and push even them to not care retail as Retail is the only one that can take such mighty weight.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.004(4.94%)
Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.5¢ 8.1¢ $46.54K 563.7K

Buyers (Bids)

No. Vol. Price($)
2 164616 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 100110 1
View Market Depth
Last trade - 15.55pm 28/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.